THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2025 (Year End)
$96,398,389
Investments
88%
Cash & Equivalents
4%
Receivables (Non-Related)
2%
Other Assets
2%
Property, Plant, & Equipment (net)
2%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2025 (Year End)
$9,058,328
Deferred Revenue
51%
Payables & Accruals
33%
Notes Payable / Debt (Non-Related)
12%
Grants Payable
5%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2024
2025
Change
Cash & Equivalents
$4,999,596
$3,935,469
-21%
Receivables (Non-Related)
$1,623,883
$2,385,648
+47%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$397,259
$339,790
-14%
Investments
$76,707,866
$85,095,778
+11%
Property, Plant, & Equipment (net)
$2,450,094
$2,278,405
-7%
Other Assets
$2,000,185
$2,363,299
+18%
Total Assets
$88,178,883
$96,398,389
+9%
Liabilities
2024
2025
Change
Payables & Accruals
$2,385,943
$2,971,694
+25%
Grants Payable
$749,480
$432,813
-42%
Deferred Revenue
$4,536,759
$4,599,672
+1%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$1,139,448
$1,054,149
-7%
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$8,811,630
$9,058,328
+3%
Net assets
2024
2025
Change
Restricted Net Assets
$25,556,941
$29,348,674
+15%
Unrestricted Net Assets
$53,810,312
$57,991,387
+8%
Net assets
2024
2025
Change
Net assets
+$79,367,253
+$87,340,061
+10%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)